logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

delete2023-02-14
delete20
delete
OA
AI
A
Antoine Vanier *
J
Judith Fernandez
S
Sophie Kelley
L
Lise Alter
P
Patrick Semenzato
C
Corinne Alberti
S
Sylvie Chevret
D
Dominique Costagliola
M
Michel Cucherat
B
Bruno Falissard
F
François Gueyffier
J
Jérôme Lambert
É
Étienne Lengliné
C
Clara Locher
F
Florian Naudet
R
Raphaël Porcher
R
Rodolphe Thiébaut
M
Muriel Vray
S
Sarah Zohar
P
Pierre Cochat
D
Dominique Le Guludec
DOI：10.1136/bmjebm-2022-112091delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En
Keywords:
TRIAL
POPULATION
DESIGN
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

B
BMJ Evidence-Based Medicine
IF:
7.6
Papers:
989
Citations:
1.9K

Organization

C
chu lyon
Scholars:
1.5W
Papers: 1.1W
Citations: 25
N
nantes universite
Scholars:
1.7W
Papers: 1.2W
Citations: 125
U
Universite Paris Cite
Scholars:
8.9W
Papers: 6.3W
Citations: 604
I
institut national de la sante et de la recherche medicale (inserm)
Scholars:
11.5W
Papers: 7.5W
Citations: 117
A
assistance publique hopitaux paris (aphp)
Scholars:
6.8W
Papers: 5.3W
Citations: 57
U
Universite Paris Saclay
Scholars:
7.2W
Papers: 5.2W
Citations: 540
S
Sorbonne Universite
Scholars:
6.1W
Papers: 4.4W
Citations: 605
researcher View more organizations